Preferred Label : Loncastuximab;
NCIt definition : A humanized immunoglobulin (Ig) G1 monoclonal antibody directed against the tumor-associated
antigen (TAA) CD19, with potential antineoplastic activity. Upon administration, loncastuximab
targets and binds to CD19 expressed on tumor cells. This may inhibit the proliferation
of CD19-overexpressing tumor cells. CD19 antigen is a B-cell specific cell surface
antigen overexpressed in B-cell lineage malignancies.;
UNII : NYM5HO7I39;
CAS number : 1875032-68-0;
NCI Metathesaurus CUI : CL1412268;
Origin ID : C174770;
UMLS CUI : C5420946;
Semantic type(s)
- chemical_or_drug_has_mechanism_of_action
- concept_is_in_subset
